Takashi Shindo

1.5k total citations
42 papers, 1.1k citations indexed

About

Takashi Shindo is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Takashi Shindo has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Pharmacology and 10 papers in Pharmacology. Recurrent topics in Takashi Shindo's work include Pharmacogenetics and Drug Metabolism (8 papers), Cardiac Imaging and Diagnostics (5 papers) and Cardiac Ischemia and Reperfusion (5 papers). Takashi Shindo is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Cardiac Imaging and Diagnostics (5 papers) and Cardiac Ischemia and Reperfusion (5 papers). Takashi Shindo collaborates with scholars based in Japan, United Kingdom and United States. Takashi Shindo's co-authors include Yoshiyuki Horio, Mitsuhiko Yamada, Chikako Kondo, Y Kurachi, S Isomoto, Sayuri Matsumoto, Takeshi Kimura, Hideyuki Nosaka, Naoya Hamasaki and Hiroatsu Yokoi and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The Journal of Physiology.

In The Last Decade

Takashi Shindo

42 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takashi Shindo Japan 10 497 388 303 268 222 42 1.1k
Masami Miyamae Japan 18 489 1.0× 647 1.7× 356 1.2× 209 0.8× 159 0.7× 39 1.3k
Jun Asayama Japan 17 541 1.1× 251 0.6× 265 0.9× 137 0.5× 96 0.4× 66 1.0k
Harley D. Sybers United States 17 531 1.1× 261 0.7× 236 0.8× 270 1.0× 227 1.0× 38 1.1k
Stephen Ely United States 16 421 0.8× 376 1.0× 150 0.5× 107 0.4× 176 0.8× 29 925
Liliane Tariosse France 14 457 0.9× 416 1.1× 355 1.2× 82 0.3× 193 0.9× 23 1.0k
R B Jennings United States 12 507 1.0× 631 1.6× 236 0.8× 134 0.5× 284 1.3× 16 1.1k
K A Reimer United States 8 330 0.7× 429 1.1× 216 0.7× 85 0.3× 144 0.6× 11 797
C. Depre United States 13 719 1.4× 227 0.6× 314 1.0× 223 0.8× 523 2.4× 18 1.2k
Laurence W.V. DeBoer United States 14 655 1.3× 441 1.1× 168 0.6× 260 1.0× 487 2.2× 31 1.2k
Hiroharu Funaya Japan 13 480 1.0× 324 0.8× 163 0.5× 90 0.3× 76 0.3× 19 938

Countries citing papers authored by Takashi Shindo

Since Specialization
Citations

This map shows the geographic impact of Takashi Shindo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Shindo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Shindo more than expected).

Fields of papers citing papers by Takashi Shindo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Shindo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Shindo. The network helps show where Takashi Shindo may publish in the future.

Co-authorship network of co-authors of Takashi Shindo

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Shindo. A scholar is included among the top collaborators of Takashi Shindo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Shindo. Takashi Shindo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamazaki, Kazuyoshi, Kikutaro Tokairin, Toshiya Osanai, et al.. (2021). Intraoperative Identification of the Shunt Point of Spinal Arteriovenous Malformations by a Selective Arterial Injection of Saline to Subtract Signals of Indocyanine Green: Technical Note. World Neurosurgery. 151. 132–137. 1 indexed citations
2.
3.
Boyeson, Michael G., et al.. (2001). Phase I study of the novel oral steroidal antiestrogenic agent TAS-108, ascending single dose, safety, tolerance, and pharmacokinetic parameters in healthy postmenopausal women. 69(3). 1 indexed citations
4.
Shindo, Takashi, Mitsuhiko Yamada, Shojiro Isomoto, Yoshiyuki Horio, & Yoshihisa Kurachi. (1998). SUR2 subtype (A and B)‐dependent differential activation of the cloned ATP‐sensitive K+ channels by pinacidil and nicorandil. British Journal of Pharmacology. 124(5). 985–991. 63 indexed citations
5.
Okuyama, Yuji, Mitsuhiko Yamada, Chikako Kondo, et al.. (1998). The effects of nucleotides and potassium channel openers on the SUR2A/Kir6.2 complex K + channel expressed in a mammalian cell line, HEK293T cells. Pflügers Archiv - European Journal of Physiology. 435(5). 595–603. 72 indexed citations
6.
Tohyama, Shugo, Takashi Shindo, Kazuhiro Shiba, et al.. (1997). [Risk of side branch occlusion after coronary Palmaz-Schatz stenting].. PubMed. 29(5). 261–6. 11 indexed citations
7.
Shioya, Takanobu, et al.. (1996). Antimuscarinic effect of tiquizium bromide in vitro and in vivo. European Journal of Clinical Pharmacology. 50(5). 375–380. 4 indexed citations
8.
Yamamoto, Yoshio, et al.. (1995). Pharmacokinetic Studies on Propiverine Hydrochloride. Metabolites in Urinary Bladder, Other Tissues and Urine of Rats.:Metabolites in Urinary Bladder, Other Tissues and Urine of Rats. 10(2). 205–210. 2 indexed citations
9.
Yamamoto, Yoshio, et al.. (1995). Pharmacokinetic Studies on Propiverine Hydrochloride. Metabolites in Urinary Bladder, Other Tissues and Urine of Rats.. Drug Metabolism and Pharmacokinetics. 10(2). 205–210. 4 indexed citations
10.
Yamamoto, Yumi, et al.. (1993). Pharmacokinetic studies of MPC-1304 (4) - Dose response, animal differences, protein binding. 21. 297–310. 1 indexed citations
11.
Nobuyoshi, Masakiyo, Masahiko Abe, Hideyuki Nosaka, et al.. (1992). Statistical analysis of clinical risk factors for coronary artery spasm: Identification of the most important determinant. American Heart Journal. 124(1). 32–38. 97 indexed citations
12.
13.
Nobuyoshi, Masakiyo, Makoto Tanaka, Hideyuki Nosaka, et al.. (1991). Progression of coronary atherosclerosis: Is coronary spasm related to progression?. Journal of the American College of Cardiology. 18(4). 904–910. 182 indexed citations
14.
Suzuki, Takashi, et al.. (1990). Pharmacokinetic studies of mofezolac. III: Differences of metabolic pathways brought by animal differences.. Drug Metabolism and Pharmacokinetics. 5(3). 429–438. 1 indexed citations
15.
Shindo, Takashi, et al.. (1990). Pharmacokinetic studies of mofezolac. II: Identification of metabolites and biotransformation of mofezolac in various animals.. Drug Metabolism and Pharmacokinetics. 5(3). 405–427. 1 indexed citations
16.
Yamamoto, Yoshio, et al.. (1989). Pharmacokinetic studies of propiverine hydrochloride (1). Absorption, distribution and excretion after a single administration to rats.. Drug Metabolism and Pharmacokinetics. 4(5). 537–551. 4 indexed citations
17.
Shindo, Takashi, et al.. (1982). Comparison of the absorption, excretion, and metabolism of suxibuzone and phenylbutazone in humans. Journal of Pharmaceutical Sciences. 71(5). 565–572. 9 indexed citations
18.
19.
Shindo, Takashi, et al.. (1979). The Biological Fate of Suxibuzone V. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 10(4). 525–533. 1 indexed citations
20.
KAWADA, JUN, Takashi Shindo, & Yoshiyuki Yoshimura. (1976). Further Study of the Mechanism of Thyroid Hormone Secretion in an in Vitro Model System: Direct Evidence for Fusion of Lysosomes with Thyroglobulin Liposomes. Endocrinology. 98(6). 1425–1429. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masami Miyamae Breakdown of academic impact, for papers by Jun Asayama Breakdown of academic impact, for papers by Harley D. Sybers Breakdown of academic impact, for papers by Stephen Ely Breakdown of academic impact, for papers by Liliane Tariosse Breakdown of academic impact, for papers by R B Jennings Breakdown of academic impact, for papers by K A Reimer Breakdown of academic impact, for papers by C. Depre Breakdown of academic impact, for papers by Laurence W.V. DeBoer Breakdown of academic impact, for papers by Hiroharu Funaya
Rankless by CCL
2026